PMI
Picard Medical, Inc.
5.80$
+33.8%
vs. previous close
Closing price · As of: Oct 2, 2026
Statements
Income Statement
All figures as a percentage of revenue in the same period.
Tick rows to compare them in a chart (up to 4)
| Line item | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 | LTM* |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | |
| 234.5% | 59.2% | 155.0% | 176.4% | 83.7% | 157.7% | 106.0% | 111.0% | 19.2% | 76.1% | 79.1% | 75.0% | |
| -134.5% | 40.8% | -55.0% | -76.4% | 16.3% | -57.7% | -6.0% | -11.0% | 80.8% | 23.9% | 20.9% | 25.0% | |
| 70.2% | 34.8% | 135.4% | 109.1% | 94.4% | 130.3% | 34.9% | 80.1% | 49.4% | 164.8% | 46.5% | 74.9% | |
| – | – | 360.5% | 319.0% | 349.2% | 335.5% | 124.4% | 202.7% | 284.1% | 251.4% | 131.0% | 191.0% | |
| 581.0% | 135.3% | 496.0% | 428.0% | 443.5% | 465.8% | 159.3% | 282.8% | 333.1% | 416.2% | 177.6% | 265.9% | |
| -715.5% | -94.5% | -551.0% | -504.4% | -427.3% | -523.5% | -165.2% | -293.8% | -252.3% | -392.3% | -156.7% | -240.8% | |
| 9.8% | 4.1% | 24.8% | 156.9% | 171.2% | 89.5% | 113.9% | 202.5% | 0.7% | 0.4% | 3.0% | 39.8% | |
| -725.7% | -98.7% | -584.6% | -704.4% | -1,059.0% | -891.9% | -315.5% | -878.3% | -428.1% | -662.3% | -191.4% | -444.7% | |
| -0.2% | – | – | – | -1.8% | 5.0% | 37.4% | – | -3.1% | – | 0.2% | – | |
| -725.4% | -98.7% | -584.6% | -704.4% | -1,057.2% | -896.9% | -352.9% | -878.3% | -425.1% | -662.3% | -191.6% | -444.3% | |
| -698.4% | -87.4% | -537.8% | -533.7% | -872.7% | -781.6% | -195.7% | -665.1% | -415.3% | -650.0% | -152.2% | -381.8% |
LTM = last twelve months (sum of the four most recent quarters).
Data as of: October 2, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.